Status:
COMPLETED
Phenotyping Liver Cancer Registry
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18-100 years
Brief Summary
The purpose of this study is the development of a content-based image retrieval (CBIR) platform, where validation studies will be conducted for liver disease subtyping and hepatocellular carcinoma (HC...
Detailed Description
The study will advance through two distinct phases. * Phase 1 has two main stages: The first stage will identify unique tumor phenotypes based on the iBiopsy phenotyping platform which extracts image...
Eligibility Criteria
Inclusion
- Patients with visual liver disease who:
- Have a lesion visualized on CT scans / MRI with histological confirmation (surgical resection, biopsy, transplant).
- With a CT scan / MRI performed within 6 months prior to biopsy, surgical or transplant intervention.
Exclusion
- Patients that had CT scans / MRI taken more than 6 months prior to surgical intervention
Key Trial Info
Start Date :
August 31 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
2429 Patients enrolled
Trial Details
Trial ID
NCT04681274
Start Date
August 31 2020
End Date
December 31 2022
Last Update
May 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique - Hôpitaux de Paris (AP-HP) Groupe Hospitalier La Pitié-Salpêtrière
Paris, Île-de-France Region, France, 75013